↓ Skip to main content

Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma

Overview of attention for article published in American Journal of Health-System Pharmacy, February 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy
1 policy source
twitter
20 X users
patent
2 patents

Readers on

mendeley
113 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma
Published in
American Journal of Health-System Pharmacy, February 2016
DOI 10.2146/ajhp140768
Pubmed ID
Authors

Igor N. Ivashko, Jill M. Kolesar

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Iran, Islamic Republic of 1 <1%
Unknown 112 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 16 14%
Student > Ph. D. Student 12 11%
Student > Bachelor 9 8%
Researcher 8 7%
Other 6 5%
Other 13 12%
Unknown 49 43%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 20 18%
Biochemistry, Genetics and Molecular Biology 15 13%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Immunology and Microbiology 5 4%
Agricultural and Biological Sciences 4 4%
Other 11 10%
Unknown 50 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2025.
All research outputs
#2,470,795
of 32,432,832 outputs
Outputs from American Journal of Health-System Pharmacy
#298
of 5,125 outputs
Outputs of similar age
#35,746
of 445,762 outputs
Outputs of similar age from American Journal of Health-System Pharmacy
#3
of 67 outputs
Altmetric has tracked 32,432,832 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,125 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,762 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.